Norepinephrine infusions into the medial preoptic area inhibit lordosis behavior
Lab / animal
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Norepinephrine infusions into the medial preoptic area of rats significantly inhibited estrogen- and progesterone-induced lordosis behavior, an effect blocked by the alpha 2-noradrenergic antagonist yohimbine.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Neurotransmitters, including norepinephrine, have been implicated in the mediation of ovarian steroid induced lordosis behavior in ovariectomized rats. In this study we have found that norepinephrine (NE) infusions into the medial preoptic area (MPOA) reduced lordosis frequencies of estrogen-progesterone treated (0.5 micrograms estradiol benzoate for three days followed by 500 micrograms progesterone 4-5 hours before testing) receptive rats. Norepinephrine doses of 2 micrograms or more per animal infused into the MPOA significantly reduced lordosis levels within five minutes. Infusions of 10 and 20 micrograms doses of NE suppressed lordosis levels for 15 minutes after infusion. At the lowest inhibitory dose (2 micrograms/animal) simultaneous infusion of 5 micrograms/microliter of the noradrenergic antagonist yohimbine, but not of phentolamine or propranolol, blocked the reduction in lordosis resulting from NE infusion. Preoptic infusions of epinephrine and clonidine were also effective in reducing lordosis quotients, while methoxamine, phenylephrine and isoproterenol did not alter receptivity. These findings are consistent with the conclusion that the direct effect of norepinephrine infusions into the MPOA is inhibition of lordosis responding. There is some evidence that this inhibitory influence is mediated by alpha 2-noradrenergic receptors.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- The influence of alpha-receptors on lordosis in the female rat 1977
- Alpha-methyltyptamine blocks facilitation of lordosis by progesterone in spayed, extrogen-primed rats 1975
Cited by (2)
References (56)
- Alpha-methyltyptamine blocks facilitation of lordosis by progesterone in spayed, extrogen-primed rats via openalex
- The influence of alpha-receptors on lordosis in the female rat via openalex
- W1522531331 via openalex
- W1606211266 via openalex
- W1964828902 via openalex
- W1966598652 via openalex
- W1967813834 via openalex
- W1971098710 via openalex
- W1972814586 via openalex
- W1975180379 via openalex
- W1979331239 via openalex
- W1980567548 via openalex
- W1985525186 via openalex
- W1986732575 via openalex
- W1996283992 via openalex
- W2002664886 via openalex
- W2004488787 via openalex
- W2006096883 via openalex
- W2010739711 via openalex
- W2014617998 via openalex
- W2018182917 via openalex
- W2024824446 via openalex
- W2026266378 via openalex
- W2028848319 via openalex
- W2031661178 via openalex
- doi:10.1007/bf01245837 via openalex
- W2047760404 via openalex
- W2057250907 via openalex
- W2065265745 via openalex
- W2065295152 via openalex
- W2072061629 via openalex
- W2075394288 via openalex
- W2082002150 via openalex
- W2085667377 via openalex
- W2088084248 via openalex
- W2088116769 via openalex
- W2119259585 via openalex
- W2132304432 via openalex
- W2162242417 via openalex
- W2175087497 via openalex
- W2281938476 via openalex
- W2315625279 via openalex
- W2325343629 via openalex
- W2336350647 via openalex
- W2410746937 via openalex
- W2417669482 via openalex
- W2418731114 via openalex
- W2795444186 via openalex
- W4243423996 via openalex
- W4289970632 via openalex
- W6604326623 via openalex
- W6669078806 via openalex
- W6699380452 via openalex
- W106863476 via openalex
- W6808319897 via openalex
- W1498891976 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:22:53.024375+00:00
- unpaywall
- last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0
· commercial use OK